|
Device | T SPOT-TB TEST |
Generic Name | Mycobacterium tuberculosis, Cell mediated immune response, enzyme-linked immunospot test |
Applicant | OXFORD IMMUNOTEC,LTD. 94C INNOVATION DRIVE MILTON PARK, ABINGDON OXFORDSHIRE OX14 |
PMA Number | P070006 |
Date Received | 02/06/2007 |
Decision Date | 07/30/2008 |
Product Code |
OJN |
Docket Number | 08M-0477 |
Notice Date | 08/26/2008 |
Advisory Committee |
Microbiology |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement APPROVAL FOR THE T-SPOT-TB. THIS DEVICE IS INDICATED FOR USE AS AN IN VITRO DIAGNOSTIC TEST FOR THE DETECTION OF EFFECTOR T CELLS THAT RESPOND TO STIMULATION BY MYCOBACTERIUM TUBERCULOSIS ANTIGENS ESAT-6 AND CFP-10 BY CAPTURING INTERFERON GAMMA (IFN-¿) IN THE VICINITY OF T CELLS IN HUMAN WHOLE BLOOD COLLECTED IN SODIUM CITRATE OR SODIUM OR LITHIUM HEPARIN. IT IS INTENDED FOR USE AS AN AID IN THE DIAGNOSIS OF M. TUBERCULOSIS INFECTION. T-SPOT-TB IS AN INDIRECT TEST FOR M. TUBERCULOSIS INFECTION (INCLUDING DISEASE) AND IS INTENDED FOR USE IN CONJUNCTION WITH RISK ASSESSMENT, RADIOGRAPHY AND OTHER MEDICAL AND DIAGNOSTIC EVALUATIONS. |
Approval Order | Approval Order |
Summary | Summary of Safety and Effectiveness |
Labeling | Labeling
|
Supplements: |
S001 S002 S003 S004 S005 S006 S007 S008 S009 S011 S012 S013 S014 S015 S016 S017 S018 S019 S020 S021 S022 S023 S025
|